Solventum Corp
For the period ended Sep 30, 2025. Filed Nov 6, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2025 · Filed Nov 6, 2025
SOLV$90.08-0.4%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Cash Flows (Unaudited)
| Nine months ended September 30, | ||
|---|---|---|
| (Millions) | 2025 | 2024 |
| Cash Flows from Operating Activities | ||
| Net income | $1,493 | $448 |
| Adjustments to reconcile net income to net cash provided by operating activities | ||
| Depreciation and amortization | 372 | 405 |
| Pension and postretirement benefit expense | 49 | 30 |
| Stock-based compensation expense | 124 | 87 |
| Gain on sale of business | (1,518) | — |
| Purification and Filtration transaction costs | (86) | — |
| Deferred income taxes | (47) | (93) |
| Changes in assets and liabilities | ||
| Accounts receivable | 36 | 14 |
| Due from related parties | 37 | 200 |
| Inventories | (134) | (99) |
| Accounts payable | 74 | 200 |
| Due to related parties | 18 | (321) |
| Accrued compensation | (9) | 53 |
| All other operating activities — net | (135) | 42 |
| Net cash provided by operating activities | 274 | 966 |
| Cash Flows from Investing Activities | ||
| Purchases of property, plant and equipment | (316) | (253) |
| Proceeds from sale of business | 3,870 | — |
| Other — net | (12) | — |
| Net cash provided by (used in) investing activities | 3,542 | (253) |
| Cash Flows from Financing Activities | ||
| Repayment of debt | (2,970) | (200) |
| Net transfers to 3M | (21) | (8,247) |
| Proceeds from long-term debt, net of issuance costs | — | 8,303 |
| Other — net | 49 | 8 |
| Net cash used in financing activities | (2,942) | (136) |
| Effect of exchange rate changes on cash and cash equivalents | 6 | 1 |
| Net increase (decrease) in cash and cash equivalents | 880 | 578 |
| Cash and cash equivalents at beginning of period | 762 | 194 |
| Cash and cash equivalents at end of period | $1,642 | $772 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.